Evidence map›Paper›PMID 26987342›Full record

ArticleScientific reports2016

Substrate engagement of integrins α5β1 and αvβ3 is necessary, but not sufficient, for high directional persistence in migration on fibronectin.

Dimitris Missirlis, Tamás Haraszti, Catharina v C Scheele, Tina Wiegand, Carolina Diaz, Stefanie Neubauer, Florian Rechenmacher, Horst Kessler, Joachim P Spatz

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Dimitris MissirlisDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Tamás HarasztiDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Catharina v C ScheeleDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Tina WiegandDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Carolina DiazDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Stefanie NeubauerInstitute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstr. 4, Garching, D-85747, Germany.
Florian RechenmacherInstitute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstr. 4, Garching, D-85747, Germany.
Horst KesslerInstitute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstr. 4, Garching, D-85747, Germany.
Joachim P SpatzDepartment of New Materials and Biosystems, Max Planck Institute for Intelligent Systems &University of Heidelberg, Department of Biophysical Chemistry Heisenbergstr. 3, D-70569 Stuttgart, Germany.
Max Planck Institute for Intelligent Systems · DECenter for Integrated Protein Science Munich · DEHeidelberg University · DEInstitute for Advanced Study · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between specific integrin-mediated matrix adhesion and directional persistence in cell migration is not well understood. Here, we characterized fibroblast adhesion and migration on the extracellular matrix glycoproteins fibronectin and vitronectin, focusing on the role of α5β1 and αvβ3 integrins. Fibroblasts manifested high directional persistence in migration on fibronectin-, but not vitronectin-coated substrates, in a ligand density-dependent manner. Fibronectin stimulated α5β1-dependent organization of the actin cytoskeleton into oriented, ventral stress fibers, and assembly of dynamic, polarized protrusions, characterized as regions free of stress fibers and rich in nascent adhesions at their edge. Such protrusions correlated with persistent, local leading edge advancement, but were not sufficient, nor necessary for directional migration over longer times. Selective blocking of αvβ3 or α5β1 integrins using small molecule integrin antagonists reduced directional persistence on fibronectin, indicating integrin cooperativity in maintaining directionality. On the other hand, patterned substrates, designed to selectively engage either integrin, or their combination, were not sufficient to establish directional migration. Overall, our study demonstrates adhesive coating-dependent regulation of directional persistence in fibroblast migration and challenges the generality of the previously suggested role of β1 and β3 integrins in directional migration.

Indexed as

AnimalsCell AdhesionCell LineCell MovementFibroblastsFibronectinsFourier AnalysisHumansIntegrin alpha5beta1Integrin alphaVbeta3Microscopy, Atomic ForceRatsSmall Molecule LibrariesFibronectinsIntegrin alpha5beta1Integrin alphaVbeta3Small Molecule Libraries

Identifiers

PMID26987342
PMCPMC4796868
OpenAlexW2297747457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.